About HistoSonics
HistoSonics is a company based in Ann Arbor (United States) founded in 2009 was acquired by K5 Global in August 2025.. HistoSonics has raised $565.73 million across 11 funding rounds from investors including Varian, University of Michigan and Fletcher Spaght. The company has 56 employees as of December 31, 2022. HistoSonics offers products and services including Histotripsy System and Clinical Trials Platform. HistoSonics operates in a competitive market with competitors including Insightec, Profound Medical, Theraclion, Carthera and SONIRE Therapeutics, among others.
- Headquarter Ann Arbor, United States
- Employees 56 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Histosonics, Inc Attn Christine
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HistoSonics
HistoSonics offers a comprehensive portfolio of products and services, including Histotripsy System and Clinical Trials Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive platform for mechanical destruction of liver tumors.
System for testing histotripsy in oncology applications.
Unlock access to complete
Unlock access to complete
Funding Insights of HistoSonics
HistoSonics has successfully raised a total of $565.73M across 11 strategic funding rounds. The most recent funding activity was a Series E round of $250 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series E — $250.0M
-
First Round
First Round
(16 May 2014)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series E - HistoSonics | Valuation |
investors |
|
| Jul, 2024 | Amount | Series D - HistoSonics | Valuation | Alpha Wave Global | |
| Dec, 2022 | Amount | Series D - HistoSonics | Valuation | Johnson & Johnson Innovation |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HistoSonics
HistoSonics has secured backing from 24 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Varian, University of Michigan and Fletcher Spaght. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on growth-stage companies
|
Founded Year | Domain | Location | |
|
Amzak Health is engaged in venture investments in life sciences.
|
Founded Year | Domain | Location | |
|
Investments are focused on tech and life sciences startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HistoSonics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HistoSonics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Histosonics Comparisons
Competitors of HistoSonics
HistoSonics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, Profound Medical, Theraclion, Carthera and SONIRE Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
|
|
| domain | founded_year | HQ Location |
Image-guided prostate ablation systems for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Provider of non-invasive robotic ultrasound therapy devices
|
|
| domain | founded_year | HQ Location |
Ultrasound-based medical devices for brain tumor treatment are developed.
|
|
| domain | founded_year | HQ Location |
High-intensity focused ultrasound systems for targeted cancer treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Histosonics
Frequently Asked Questions about HistoSonics
When was HistoSonics founded?
HistoSonics was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Where is HistoSonics located?
HistoSonics is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Who is the current CEO of HistoSonics?
Mike Blue is the current CEO of HistoSonics.
Is HistoSonics a funded company?
HistoSonics is a funded company, having raised a total of $565.73M across 11 funding rounds to date. The company's 1st funding round was a Series D of $85M, raised on May 16, 2014.
How many employees does HistoSonics have?
As of Dec 31, 2022, the latest employee count at HistoSonics is 56.
What does HistoSonics do?
HistoSonics was founded in 2009 in Ann Arbor, United States, and focuses on medical technology within the ultrasound therapeutics sector. Histotripsy technology, licensed from the University of Michigan, is developed as a non-invasive, image-guided system that uses pulsed sound waves to create cavitation for mechanical tissue destruction at the cellular level. Applications span cardiovascular, oncology, neurology, and urology fields, targeting tumors, plaque, and other tissues.
Who are the top competitors of HistoSonics?
HistoSonics's top competitors include Insightec, Profound Medical and Theraclion.
What products or services does HistoSonics offer?
HistoSonics offers Histotripsy System and Clinical Trials Platform.
Who are HistoSonics's investors?
HistoSonics has 24 investors. Key investors include Varian, University of Michigan, Fletcher Spaght, Signature NY, and Early Stage Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.